Xie Ashleigh, Tjahjono Richard, Phan Kevin, Yan Tristan D
1 The Collaborative Research (CORE) Group, Macquarie University, Sydney, Australia ; 2 Department of Cardiothoracic Surgery, Royal Prince Alfred Hospital, Sydney, Australia ; 3 University of Sydney, Sydney, Australia.
Ann Cardiothorac Surg. 2015 Nov;4(6):495-508. doi: 10.3978/j.issn.2225-319X.2015.08.01.
Video-assisted thoracoscopic surgery (VATS) thymectomy is an increasingly utilized alternative to traditional open approaches for the resection of thymomas. Recent studies have suggested comparable survival and oncological efficacy as well as reduced perioperative morbidity when using the VATS approach. This current systematic review thus aimed to critically evaluate existing evidence for the efficacy and safety of VATS versus open (transsternal or transthoracic) thymectomy for thymomas.
Six electronic databases were searched from their date of inception to April 2015. Relevant studies were identified using specific eligibility criteria and data were extracted and analyzed based on predefined primary and secondary endpoints.
Fourteen comparative observational studies with a total of 1,061 patients were obtained for qualitative assessment, data extraction and analysis. Five-year overall survival and 10-year recurrence-free survival was similar or higher in patients undergoing VATS compared to open thymectomy. On average, the VATS group also demonstrated reduced intraoperative blood loss (131.8 vs. 340.5 mL), shorter hospital stays (7.0 vs. 9.8 days), and lower rates of postoperative pneumonia (1.9% vs. 4.1%). The mean rate of conversion from VATS to open thymectomy was relatively low (3.1%), while 30-day mortality remained low in both the VATS and open groups (0 vs. 0.3%).
The current evidence suggests that VATS thymectomy for thymoma has at least equal if not superior oncological efficacy and survival outcomes, as well as reduced perioperative complications, compared to open surgery. Further adequately powered studies and future randomized trials are required to confirm these findings.
电视辅助胸腔镜手术(VATS)胸腺切除术是一种越来越多地被用于替代传统开放手术切除胸腺瘤的方法。最近的研究表明,使用VATS方法时,其生存率和肿瘤学疗效相当,且围手术期发病率降低。因此,本系统评价旨在严格评估VATS与开放(经胸骨或经胸)胸腺切除术治疗胸腺瘤的疗效和安全性的现有证据。
检索了六个电子数据库,检索时间从其创建之日至2015年4月。使用特定的纳入标准确定相关研究,并根据预先定义的主要和次要终点提取和分析数据。
共获得14项比较性观察性研究,涉及1061例患者,用于定性评估、数据提取和分析。与开放胸腺切除术相比,接受VATS的患者5年总生存率和10年无复发生存率相似或更高。平均而言,VATS组还表现出术中失血量减少(131.8 vs. 340.5 mL)、住院时间缩短(7.0 vs. 9.8天)以及术后肺炎发生率较低(1.9% vs. 4.1%)。VATS转为开放胸腺切除术的平均发生率相对较低(3.1%),而VATS组和开放组的30天死亡率均较低(0 vs. 0.3%)。
目前的证据表明,与开放手术相比,VATS胸腺切除术治疗胸腺瘤至少具有同等甚至更好的肿瘤学疗效和生存结果,以及更低的围手术期并发症。需要进一步进行有足够样本量的研究和未来的随机试验来证实这些发现。